Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression
about
Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseasesBone morphogenetic protein 4 promotes vascular smooth muscle contractility by activating microRNA-21 (miR-21), which down-regulates expression of family of dedicator of cytokinesis (DOCK) proteinsMechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle DisordersRegulatory RNAs controlling vascular (dys)function by affecting TGF-ß family signallingDevelopmental roles of tribbles protein family membersMicromanaging vascular smooth muscle cell differentiation and phenotypic modulationInduction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferationA Review of the Scaffold Protein Menin and its Role in Hepatobiliary Pathology.Epigenetics: an expanding new piece of the stroke puzzleSweating the small stuff: microRNAs and genetic changes define pancreatic cancer.PDGF: the nuts and bolts of signalling toolbox.miR-15b induced by platelet-derived growth factor signaling is required for vascular smooth muscle cell proliferationCardiovascular importance of the microRNA-23/27/24 family.Mechanisms of control of microRNA biogenesis.Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseasesMicroRNA-450a-3p represses cell proliferation and regulates embryo development by regulating Bub1 expression in mouse.Regulation of TRIB3 mRNA and protein in breast cancer.microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis.The amiloride derivative phenamil attenuates pulmonary vascular remodeling by activating NFAT and the bone morphogenetic protein signaling pathway.MicroRNA-24 antagonism prevents renal ischemia reperfusion injuryMiR-24 promotes the survival of hematopoietic cellsInvolvement of microRNA-24 and DNA methylation in resistance of nasopharyngeal carcinoma to ionizing radiationMicroRNA-21 is induced by rapamycin in a model of tuberous sclerosis (TSC) and lymphangioleiomyomatosis (LAM).Expression profile of microRNAs regulating proliferation and differentiation in mouse adult cardiac stem cellsMicroRNA in Cancer: The Involvement of Aberrant MicroRNA Biogenesis Regulatory PathwaysContribution of intestinal smooth muscle to Crohn's disease fibrogenesisFunctional microRNA library screening identifies the hypoxamir miR-24 as a potent regulator of smooth muscle cell proliferation and vascularizationPDGF induced microRNA alterations in cancer cells.MiR-24 is required for hematopoietic differentiation of mouse embryonic stem cells.down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4Mechanical stretch suppresses microRNA-145 expression by activating extracellular signal-regulated kinase 1/2 and upregulating angiotensin-converting enzyme to alter vascular smooth muscle cell phenotypemiR-200c regulates FGFR-dependent epithelial proliferation via Vldlr during submandibular gland branching morphogenesisHypoxia potentiates microRNA-mediated gene silencing through posttranslational modification of Argonaute2.Small-nucleic-acid-based therapeutic strategy targeting the transcription factors regulating the vascular inflammation, remodeling and fibrosis in atherosclerosisTransforming growth factor-β and smooth muscle differentiationImplication of the miR-184 and miR-204 competitive RNA network in control of mouse secondary cataract.DiGeorge syndrome critical region 8 (DGCR8) protein-mediated microRNA biogenesis is essential for vascular smooth muscle cell development in miceGeneration of vascular endothelial and smooth muscle cells from human pluripotent stem cells.Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression.The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis.
P2860
Q21245705-990D466B-B51D-4A63-8411-428FB48ACFDFQ24299613-0175E640-9D73-43DF-969C-DE7C075D3485Q26753129-5A51DE35-93F1-45BA-A809-DD7AF039A277Q26767134-8AF330E6-7192-4AA9-969E-4EEA26CE9B3DQ26828448-CAEF8B02-ED2A-4A70-BCC0-A684BEE9B91BQ27026074-6E7BE01E-B9DF-498A-BC68-D085EC0DE7C2Q28297726-49C18691-9835-4804-BBD7-69320B2FC440Q30401808-105380A9-805B-4A28-BF24-D84F7767DC88Q33352309-44FC2DEC-C068-4970-B8C8-101DC5A066D1Q33862088-8F4051AD-FF38-4E0E-8415-CF0D26DEBC99Q33965086-509FC750-C646-49C3-AA04-FFE635526111Q34049293-5C0CC5A3-088D-4773-A87F-3B0F7BBCA022Q34237674-ECA63359-1DA5-4697-B7F0-F1871ACFF573Q34310633-C0C32B69-02C5-48DB-B474-EA8C1AF8C15FQ34391443-1AAB6B47-DAC5-45ED-9B11-62246A27B5A8Q34460739-0D9C22FF-F6B1-4F76-B8C3-6563CABA523DQ34490037-1401D637-EE97-43D5-B86C-7CA9B56B9A13Q34504964-77C29329-9837-43F3-BF7A-DEF4C766EE8AQ34528387-E20F57DD-8B1B-458F-A3A7-F373FA24F079Q34568822-5C2427E4-2C69-42DD-BCEC-DB42718394EDQ34576525-83215868-C87D-45F7-9C22-121AF8F4874BQ34646522-FCF89C36-DC86-435F-856E-F16AEB6BC32DQ34652936-D6559456-4138-4163-9A4A-535AD58EEDB0Q34729987-5EF6A076-C39B-424E-9E36-CE33B3AE4EB2Q34868281-93C93D6F-E93C-4985-83CA-8F143398F5B5Q34905520-F074D44F-C27B-45C8-B108-84F3D3A72DA2Q34996380-2E0DC001-B591-4299-BB8B-1A2C55182D1BQ35017837-7427E0ED-4515-405C-BCA2-5D8081885EA0Q35027062-9DE8CEA4-4C7D-406A-BAD2-CCD3E1631CAFQ35150101-6EBB5E5F-7474-4CDC-9E9C-37AC77D98D10Q35172003-877B24B9-ACE5-4E7B-9523-031D7C59C56AQ35595481-0E2150E4-3450-4E4A-9E0A-03D18044BC6DQ35598832-2C1607C8-D815-4458-8B4F-A506B1448B77Q35723980-C8285F5D-35F6-4F55-BA9B-FEB13E168E51Q35852389-B47E410C-D144-4AB4-83BF-AB99BC1D5B55Q35973315-391D74BE-A62A-4A58-AB22-ED2504547A0DQ36003649-AF7A475D-7988-4E0B-8DDF-5912B5902C74Q36051205-19F52AE1-25E2-443C-AD84-2935E77D544EQ36099935-D3B0193D-AABD-4928-B1BF-8CB3AF4D75BAQ36158807-CA4458FB-C927-436B-BB5B-CB7E2B0190DD
P2860
Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Molecular basis for antagonism ...... y control of miR-24 expression
@ast
Molecular basis for antagonism ...... y control of miR-24 expression
@en
type
label
Molecular basis for antagonism ...... y control of miR-24 expression
@ast
Molecular basis for antagonism ...... y control of miR-24 expression
@en
prefLabel
Molecular basis for antagonism ...... y control of miR-24 expression
@ast
Molecular basis for antagonism ...... y control of miR-24 expression
@en
P2093
P2860
P356
P1433
P1476
Molecular basis for antagonism ...... y control of miR-24 expression
@en
P2093
Aaron C Hilyard
Akiko Hata
Ashish Lal
Brandi N Davis
Giorgio Lagna
Judy Lieberman
Mun Chun Chan
Nicholas S Hill
P2860
P304
P356
10.1038/EMBOJ.2009.370
P407
P577
2009-12-17T00:00:00Z